Skip to content
GLP-1 Clinics Nearby
Medication landscapeJuly 24, 2026 · 8 min read

GLP-1 medications: names, uses, and the differences that matter

“GLP-1” describes a medication family, not one interchangeable product. The active ingredient, brand, FDA-approved use, formulation, and care plan all matter.

Edited by

· Co-founder & CTO, Savo Group

B.S. in Computer Science, Oregon State University · B.A. in Psychology, University of Washington, Seattle

GLP-1 medication consultation comparing semaglutide, tirzepatide, and treatment options

Current status

Category overview

Includes approved medications, different brand indications, and investigational products.

GLP-1-only example
Semaglutide
Dual-receptor example
Tirzepatide
Prescription required
Yes
At a glance

The GLP-1 medication landscape

Start with the active ingredient and receptor action, then identify the exact product and its current regulatory status.

Swipe horizontally to compare →

The GLP-1 medication landscape. Start with the active ingredient and receptor action, then identify the exact product and its current regulatory status.
Active ingredientHow it is commonly describedWeight-care status
SemaglutideGLP-1 receptor agonistWegovy has FDA-approved chronic weight-management uses for eligible patients.
TirzepatideGIP and GLP-1 receptor agonistZepbound has FDA-approved chronic weight-management uses for eligible patients.
RetatrutideGIP, GLP-1, and glucagon receptor agonistInvestigational. There is no FDA-approved retatrutide product.

Table source:FDA drug labels and unapproved GLP-1 information

01

What “GLP-1 medication” actually means

GLP-1 receptor agonists mimic activity from a hormone involved in blood-glucose regulation, appetite, and digestion. The category includes several active ingredients, delivery formats, brands, and FDA-approved uses.

Tirzepatide is often discussed alongside GLP-1 medications, but it acts at both GIP and GLP-1 receptors. Retatrutide is a different investigational molecule that acts at three receptors and is not FDA approved.

A clinic page that says only “GLP-1 available” is therefore incomplete. A useful consultation should identify the exact active ingredient, product, formulation, intended use, and follow-up plan.

02

Active ingredient, brand, and indication are separate facts

Semaglutide appears in products with different names and approved uses. Wegovy is the semaglutide brand associated with chronic weight management, while Ozempic and Rybelsus have diabetes-related indications. Tirzepatide appears as Zepbound for chronic weight management and Mounjaro for type 2 diabetes.

Those names should not be used as casual synonyms. When comparing a clinic or online program, ask what product is actually prescribed rather than assuming the advertised molecule identifies the brand or FDA-approved use.

  • Active ingredient: the medication molecule, such as semaglutide or tirzepatide.
  • Brand: the marketed product name, such as Wegovy or Zepbound.
  • Indication: the use reviewed and approved by FDA for that product.
  • Formulation: the exact product and delivery format being dispensed.

03

The medication is only one part of the program

Two programs advertising the same active ingredient can provide very different care. One may include live clinician visits, lab coordination, nutrition support, and between-visit messaging. Another may separate each service or provide mostly refill contact.

Compare the continuing price, who evaluates eligibility, where the prescription is filled, how side effects are handled, and what happens if coverage or supply changes. Those details determine what the experience looks like after the first checkout.

Do not combine or switch GLP-1 medicines on your own. Medication selection and changes belong in a conversation with a qualified prescriber.

04

Questions that turn a vague offer into a real comparison

Bring the same questions to local clinics and online providers. Clear answers make it easier to compare programs without treating an advertisement as a care plan.

  • Which active ingredient and product are you offering?
  • Is it FDA approved for the reason it is being prescribed?
  • Is the medication brand-name, compounded, or sent through insurance?
  • Who evaluates me and who answers clinical questions after treatment begins?
  • What do membership, medication, labs, shipping, and dose changes cost?
  • What is the process if I experience side effects or need to stop?

Common questions

Answers to clarify the comparison

Is every weight-loss injection a GLP-1 medication?
No. Medication classes and mechanisms differ. Ask for the active ingredient and exact product instead of relying on a broad marketing label.
Are Ozempic and Wegovy the same thing?
They contain semaglutide, but they are distinct products with different FDA-approved indications and labeling. A prescriber should identify the product and intended use.
Is tirzepatide a GLP-1?
Tirzepatide acts at both GIP and GLP-1 receptors. It is commonly grouped into GLP-1 care comparisons, but its mechanism is not identical to semaglutide.

Primary sources

Read the official material behind this page

Health information is educational and does not diagnose, determine eligibility, or replace product labeling and care from a qualified professional.